Earnings call: Simulations Plus reports strong Q2 growth, eyes M&A By Investing.com
[ad_1] Simulations Plus , Inc. (NASDAQ:), a prominent player in biosimulation for drug discovery and development, has reported a robust 16% revenue growth for the...